Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.72 |
| ▸ | POLA1 | P09884 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.50 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.50 |
| ▸ | PNP | P00491 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL264545 | 1.00 | KDM4E (0.72) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL20346237 | 1.00 | KDM4E (0.72) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL25507075 | 1.00 | KDM4E (0.72) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL12714741 | 1.00 | KDM4E (0.72) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL10068104 | 1.00 | KDM4E (0.72) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL25504735 | 0.93 | KDM4E (0.65) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL17676619 | 0.93 | KDM4E (0.65) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL9340939 | 0.92 | KDM4E (0.64) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL6332159 | 0.92 | KDM4E (0.64) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 | |
| SCHEMBL6332162 | 0.92 | KDM4E (0.64) | KDM4EPOLA1HIF1ATAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4606903-A1 | METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEOSIDE CONTAINING PROTECTING GROUP, AND COMPOSITION | Asymchem Life Science (Tianjin) Co., Ltd (CN) | 2025-08-27 | — | — | EP | claimed |
| WO-2024082545-A1 | METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEOSIDE CONTAINING PROTECTING GROUP, AND COMPOSITION | 凯莱英生命科学技术(天津)有限公司 | 2024-04-25 | — | — | WO | claimed |
| US-20260125413-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | AM CHEMICALS LLC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260117148-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | FUJIFILM CORP (JP) | 2026-04-30 | — | — | US | disclosed |
| US-20250320430-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | FUJIFILM CORP (JP) | 2025-10-16 | — | — | US | disclosed |
| EP-4606903-A1 | METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEOSIDE CONTAINING PROTECTING GROUP, AND COMPOSITION | Asymchem Life Science (Tianjin) Co., Ltd (CN) | 2025-08-27 | — | — | EP | disclosed |
| EP-4577539-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | AM Chemicals Llc (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025134877-A1 | KIT AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE | FUJIFILM CORPORATION (JP) | 2025-06-26 | — | — | WO | disclosed |
| US-20250129308-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | FUJIFILM CORP (JP) | 2025-04-24 | — | — | US | disclosed |
| US-20250017209-A1 | COMPOSITION, MANUFACTURING METHOD FOR SEMICONDUCTOR ELEMENT, AND CLEANING METHOD FOR SEMICONDUCTOR SUBSTRATE | FUJIFILM CORPORATION (JP) | 2025-01-16 | — | — | US | disclosed |
| US-20240400942-A1 | CLEANING COMPOSITION AND CLEANING METHOD OF SEMICONDUCTOR SUBSTRATE | FUJIFILM CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| US-5142047-A | Morpholino nucleosides for blocking targeted genetic sequence | ANTI-GENE DEVELOPMENT GROUP (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0216860-A4 | STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS. | SUMMERTON JAMES (US) | 1989-02-22 | — | — | EP | disclosed |
| EP-0215942-A4 | POLYNUCLEOTIDE ASSAY REAGENT AND METHOD. | SUMMERTON JAMES | 1988-08-23 | — | — | EP | disclosed |
| EP-0216860-A1 | STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS. | SUMMERTON JAMES (US) | 1987-04-08 | — | — | EP | disclosed |
| EP-0215942-A1 | POLYNUCLEOTIDE ASSAY REAGENT AND METHOD. | SUMMERTON JAMES | 1987-04-01 | — | — | EP | disclosed |
| WO-1986005519-A1 | POLYNUCLEOTIDE ASSAY REAGENT AND METHOD | SUMMERTON JAMES | 1986-09-25 | — | — | WO | disclosed |
| WO-1986005518-A1 | STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS | SUMMERTON JAMES | 1986-09-25 | — | — | WO | disclosed |
| EP-0169787-A1 | Use of oligonucleotides bonded to an intercalating agent as drugs | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1986-01-29 | — | — | EP | disclosed |
| EP-0090789-A1 | Chemical DNA synthesis | MONSANTO COMPANY (US) | 1983-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117148-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | TPMT, P2RY13, TST | KDM4E 3987/4885POLA1 1028/4885HIF1A 4806/4885 |
| US-20250017209-A1 | COMPOSITION, MANUFACTURING METHOD FOR SEMICONDUCTOR ELEMENT, AND CLEANING METHOD FOR SEMICONDUCTOR SUBSTRATE | SPOUT1, SRM, SMOX | KDM4E 2023/4885POLA1 20/4885HIF1A 3415/4885 |
| US-20260125413-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | SSU72, NSUN2, POLR2H | KDM4E 1515/4885POLA1 54/4885HIF1A 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.